Low Seroprevalence Of Brucella Spp. Among Remote Colombian Communities From The Sierra Nevada De Santa Marta-Reference-Cited by-同舟云学术

Low Seroprevalence Of Brucella Spp. Among Remote Colombian Communities From The Sierra Nevada De Santa Marta

Published:2023-08-04 Issue:2 Volume:1 Page:30-39
ISSN:2641-9181
Container-title:International Journal of Negative Results
language:en
Short-container-title:IJNR

Author:

Oakley Regina¹,Kann Simone²,Plag Michèle³,Concha Gustavo⁴,Dreyfus Anou⁵,.Paris Daniel H¹

Affiliation:

1. Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland

2. medmissio, Institute for Global Health, Würzburg, Germany

3. Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland 2medmissio, Institute for Global Health, Würzburg, Germany

4. Organización Wiwa Yugumaiun Bunkuanarua Tairona, Valledupar, Colombia

5. Vetsuisse Faculty, University of Zürich, Zurich, Switzerland

Abstract

Brucella species cause a high burden of disease globally, infecting both humans and animals; however, One Health has been under-appreciated in Colombia. This study aimed to determine the seroprevalence of Brucella spp. in two remote indigenous communities from the Sierra Nevada de Santa Marta, Colombia. These communities live in close contact with their livestock, indicating a potential susceptibility to zoonotic pathogens. The livestock routinely kept by these communities include cattle, small ruminants and pigs, the known hosts of human pathogenic Brucella spp.. A low level of exposure to Brucella spp. was documented, with only one positive participant among 539 participants (0.2%; 95% CI 0.0 – 1.0). Nevertheless, due to the high risk that zoonoses pose, we recommend discussions with the community for the potential establishment of One Health surveillance studies for the early detection and prevention of future zoonotic disease threats.

Publisher

Open Access Pub

Subject

Pharmacology (medical)

Reference54 articles.

1. McDermott, J., Grace, D. & Zinsstag, J. (2013) Economics of brucellosis impact and control in low-income countries. doi:10.20506/rst.32.1.2197. Rev Sci Tech 32, 249-261.

2. Elbehiry, A. Aldubaib, M. Marzouk, E. Abalkhail, A. Almuzaini, A. M. et al. (2023) The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas. doi:10.3390/vaccines11030654. Vaccines (Basel) 11.

3. Franco, M. P., Mulder, M., Gilman, R. H. & Smits, H. L. (2007) Human brucellosis. doi:https://doi.org/10.1016/S1473-3099(07)70286-4. The Lancet Infectious Diseases 7, 775-786.

4. Galińska, E. M. & Zagórski, J. (2013) Brucellosis in humans--etiology, diagnostics, clinical forms. Ann Agric Environ Med 20, 233-238.

5. Ducrotoy, M. J. Ammary, K. Ait Lbacha, H. Zouagui, Z. Mick, V. et al. (2015) Narrative overview of animal and human brucellosis in Morocco: intensification of livestock production as a driver for emergence? doi:10.1186/s40249-015-0086-5. Infect Dis Poverty 4(57).